|
1
|
Metastatic carcinoid tumors: a clinical review.
|
Oncologist
|
2005
|
2.80
|
|
2
|
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.
|
Neuroendocrinology
|
2012
|
2.12
|
|
3
|
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
|
Gastroenterology
|
2002
|
2.06
|
|
4
|
Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.
|
Dis Colon Rectum
|
2002
|
1.91
|
|
5
|
Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
|
Hum Pathol
|
2002
|
1.47
|
|
6
|
Screening behavior of individuals at high risk for colorectal cancer.
|
Gastroenterology
|
2005
|
1.39
|
|
7
|
Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.
|
Cancer
|
2003
|
1.19
|
|
8
|
Dynamic Bayesian networks as prognostic models for clinical patient management.
|
J Biomed Inform
|
2008
|
1.16
|
|
9
|
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry.
|
Eur J Cancer
|
2013
|
1.05
|
|
10
|
Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
|
J Clin Oncol
|
2009
|
1.00
|
|
11
|
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
|
Neuroendocrinology
|
2008
|
0.98
|
|
12
|
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
|
Eur J Cancer
|
2011
|
0.96
|
|
13
|
The role of parallel stent insertion in patients with esophagorespiratory fistulas.
|
Gastrointest Endosc
|
2002
|
0.95
|
|
14
|
Detection of small-bowel neuroendocrine tumors by video capsule endoscopy.
|
Gastrointest Endosc
|
2006
|
0.94
|
|
15
|
Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling.
|
Hered Cancer Clin Pract
|
2007
|
0.93
|
|
16
|
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.
|
Clin Chem
|
2004
|
0.89
|
|
17
|
Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).
|
Neuroendocrinology
|
2007
|
0.83
|
|
18
|
Predicting carcinoid heart disease with the noisy-threshold classifier.
|
Artif Intell Med
|
2006
|
0.83
|
|
19
|
Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.
|
Tumour Biol
|
2011
|
0.80
|
|
20
|
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation.
|
World J Surg Oncol
|
2005
|
0.80
|
|
21
|
Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors.
|
Nucl Med Commun
|
2011
|
0.78
|
|
22
|
Selecting treatment strategies with dynamic limited-memory influence diagrams.
|
Artif Intell Med
|
2007
|
0.77
|
|
23
|
[131I]MIBG radionuclide therapy in carcinoid syndrome.
|
Eur J Surg Oncol
|
2002
|
0.75
|
|
24
|
Carcinoid heart disease.
|
N Engl J Med
|
2003
|
0.75
|
|
25
|
On the use of vignettes for eliciting test-selection strategies.
|
Stud Health Technol Inform
|
2003
|
0.75
|